TRS - TriMas Corporation 0 WATCHERS

User Comments Most Liked Latest

Login to join the conversation.

No comments yet. Be the first!

Reddit Mentions Today Week Month

u/dbasea in r/stocks • 6 days, 12 hours ago

You're close: MBS are bonds backed by pools of mortgages, and subprime mortgage bonds are just MBS where most loans are to riskier borrowers. CDOs repackage slices of many bonds (often MBS) into new tranches; CDS are insurance-like contracts on default, synthetic CDOs are built from CDS so they’re pure …

u/go_go_tindero in r/stocks • 1 week ago

A CDO is a pool of debt (any kind) sliced into tranches. Tranches is just another word for cash flow waterfall. A CLO is a different kind of CDO (consisting of company loans (mostly from LBO's)). A MBS is an unslided debt type. it is purely pass through without slicing. …

u/lykosen11 in r/stocks • 1 week ago

You should learn that using Google or even an LLM will get you answers faster and more accurately than making a reddit post lol. Whag are you even doing? A Mortgage-Backed Security (MBS) is just a big basket of home loans. When you buy a piece of an MBS, you …

u/Martin_2704 in r/StocksAndTrading • 1 week, 4 days ago

Newron Pharmaceuticals- Again Up 12% - more to come🚀🚀🚀 ​ 🚀 Strong Buy Recommendation: Newron Pharmaceuticals S.p.A. (ISIN: IT0004147952) The stock of Newron Pharmaceuticals is recommended as a Highly Speculative Buy. This recommendation is driven by the unique, blockbuster potential of its lead candidate, Evenamide, in treating Treatment-Resistant Schizophrenia (TRS), …

u/Martin_2704 in r/smallstreetbets • 2 weeks, 3 days ago

Newron Pharmaceuticals: Still under investors radar 🚀 Strong Buy Recommendation: Newron Pharmaceuticals S.p.A. (ISIN: IT0004147952) The stock of Newron Pharmaceuticals is recommended as a Highly Speculative Buy. This recommendation is driven by the unique, blockbuster potential of its lead candidate, Evenamide, in treating Treatment-Resistant Schizophrenia (TRS), and the massive valuation …

u/Martin_2704 in r/pennystocks • 2 weeks, 3 days ago

Newron Pharmaceuticals- Strong Buy Recommendation 🚀 Strong Buy Recommendation: Newron Pharmaceuticals S.p.A. (ISIN: IT0004147952) The stock of Newron Pharmaceuticals is recommended as a Highly Speculative Buy. This recommendation is driven by the unique, blockbuster potential of its lead candidate, Evenamide, in treating Treatment-Resistant Schizophrenia (TRS), and the massive valuation gap …

Related News

No related news found for this ticker.

Badges / Notes

  • No notable badges.
Short Interest: 8.98%
Days to Cover: 4.70
Dark Pool Volume
Short: 37.6% Long: 62.4%
112336 shares 186539 shares

Total Off-Exchange Volume: 298875
Values over 50% Short often indicate hidden bearish pressure from institutions.

Date: Dec 05, 2025

🏆 Master Buzz Score: 3/15

📢 Social Hype
Low Activity
💰 Smart Money
Whales own > 50%
★★
🧨 Squeeze Potential
Low Risk

Capitol Trades

DatePoliticianAmount
No recent trades found.

Insider Trades

DateInsiderValue
No recent trades found.

Institutional Holdings (Whales)

Institution Shares Value % Held Date
Bank of America Corporation 3,810,233 $129.8 million 0.0937% Sep 30, 2025
Vanguard Group Inc 3,574,064 $121.8 million 0.0879% Sep 30, 2025
Capital International Investors 2,890,079 $98.5 million 0.0711% Sep 30, 2025
Blackrock Inc. 2,505,289 $85.4 million 0.0616% Sep 30, 2025
Allspring Global Investments Holdings, LLC 2,488,390 $84.8 million 0.0612% Sep 30, 2025
Dimensional Fund Advisors LP 2,220,060 $75.6 million 0.0546% Sep 30, 2025
Pzena Investment Management LLC 1,302,265 $44.4 million 0.0320% Sep 30, 2025
State Street Corporation 894,369 $30.5 million 0.0220% Sep 30, 2025
Massachusetts Financial Services Co. 886,271 $30.2 million 0.0218% Sep 30, 2025
Geode Capital Management, LLC 875,737 $29.8 million 0.0215% Sep 30, 2025